Item 5. Market for the Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

5K characters. Original on sec.gov · Markdown

Item 5. Market for the Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Our common stock is listed on the New York Stock Exchange with the ticker symbol “A”. As of December 2, 2020, there were 20,173 common stockholders of record.

The information required by this item with respect to equity compensation plans is included under the caption "Equity Compensation Plans" in our Proxy Statement for the Annual Meeting of Stockholders to be held March 17, 2021, to be filed with the Securities and Exchange Commission pursuant to Regulation 14A, and is incorporated herein by reference.

STOCK PRICE PERFORMANCE GRAPH

The graph below shows the cumulative total stockholder return on our common stock with the cumulative total return of the S&P 500 Index and our peer group, consisting of all companies in the Health Care and Materials Indexes of the S&P 500, assuming an initial investment of $100 on October 31, 2015 and the reinvestment of all dividends.

Agilent’s stock price performance shown in the following graph is not indicative of future stock price performance. The data for this performance graph was compiled for us by Standard and Poor’s.

a-20201031_g1.jpg

INDEXED RETURNS
BaseYears Ending
Period
Company Name / Index10/31/201510/31/201610/31/201710/31/201810/31/201910/31/2020
Agilent Technologies100116.63183.87176.70208.42283.31
S&P 500100104.51129.21138.70158.57173.97
Peer Group10099.21123.71134.82147.29163.88

ISSUER PURCHASES OF EQUITY SECURITIES

The table below summarizes information about the company’s purchases, based on trade date, of its equity securities registered pursuant to Section 12 of the Exchange Act during the quarterly period ended October 31, 2020. The total number of shares of common stock purchased by the company during the fiscal year ended October 31, 2020 was 5,227,273 shares.

PeriodTotal Number of Shares of Common Stock Purchased(1)Weighted Average Price Paid per Share of Common Stock(2)Total Number of Shares of Common Stock Purchased as Part of Publicly Announced Plans or Programs(1)Maximum Approximate Dollar Value of Shares of Common Stock that May Yet Be Purchased Under the Plans or Programs (in millions)(1)
August 1, 2020 through August 31, 2020526,247$98.38526,247$756
September 1, 2020 through September 30, 20201,041,643$98.981,041,643$653
October 1, 2020 through October 31, 2020908,745$104.62908,745$558
Total2,476,635$100.922,476,635

(1)On November 19, 2018 we announced that our board of directors had approved a new share repurchase program (the "2019 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2019 repurchase program authorizes the purchase of up to $1.75 billion of our common stock at the company's discretion and has no fixed termination date. As of October 31, 2020, we had remaining authorization to repurchase up to $558 million of our common stock under this program. The 2019 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. As of October 31, 2020, all repurchased shares have been retired.

(2)The weighted average price paid per share of common stock does not include the cost of commissions.

Previous: Item 4. Mine Safety Disclosures · Next: Item 6. Selected Financial Data